Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization
Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human a...
Saved in:
Published in | The Journal of clinical investigation Vol. 65; no. 2; pp. 268 - 276 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.02.1980
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human alveolar macrophages (AM) were studied from eight subjects. With in vitro culture, AM produced and released two substances into culture media which have potent chemoattractant activity for blood polymorphonuclear granulocytes (PMN) and negligible activity for mononuclear cells. Release of these factors is maximally stimulated by aggregated human immunoglobulin (Ig)G or zymosan particles; however, simple adhesion of the macrophages to plastic surfaces is also sufficient to stimulate release of these chemotactic substances. The larger substance (10,000 daltons) is immunologically distinct from C5a and interacts with a different PMN membrane receptor than that known to exist for formyl-methionyl-leucyl-phenylalanine. Its chemotactic activity is sensitive to the enzymatic effect of trypsin. Although producing a single elution peak on gelfiltration chromatography, electrofocusing in polyacrylamide gels yielded five peaks of radioactivity. Chemotactic activity was localized to a fraction with a pI = 5.0. The smaller molecular weight substance has been less well characterized. Thus, the human AM can produce at least two factors which attract PMN and this capability may augment the local inflammatory response in the lung. |
---|---|
AbstractList | Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human alveolar macrophages (AM) were studied from eight subjects. With in vitro culture, AM produced and released two substances into culture media which have potent chemoattractant activity for blood polymorphonuclear granulocytes (PMN) and negligible activity for mononuclear cells. Release of these factors is maximally stimulated by aggregated human immunoglobulin (Ig)G or zymosan particles; however, simple adhesion of the macrophages to plastic surfaces is also sufficient to stimulate release of these chemotactic substances. The larger substance (10,000 daltons) is immunologically distinct from C5a and interacts with a different PMN membrane receptor than that known to exist for formyl-methionyl-leucyl-phenylalanine. Its chemotactic activity is sensitive to the enzymatic effect of trypsin. Although producing a single elution peak on gelfiltration chromatography, electrofocusing in polyacrylamide gels yielded five peaks of radioactivity. Chemotactic activity was localized to a fraction with a pI = 5.0. The smaller molecular weight substance has been less well characterized. Thus, the human AM can produce at least two factors which attract PMN and this capability may augment the local inflammatory response in the lung.Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human alveolar macrophages (AM) were studied from eight subjects. With in vitro culture, AM produced and released two substances into culture media which have potent chemoattractant activity for blood polymorphonuclear granulocytes (PMN) and negligible activity for mononuclear cells. Release of these factors is maximally stimulated by aggregated human immunoglobulin (Ig)G or zymosan particles; however, simple adhesion of the macrophages to plastic surfaces is also sufficient to stimulate release of these chemotactic substances. The larger substance (10,000 daltons) is immunologically distinct from C5a and interacts with a different PMN membrane receptor than that known to exist for formyl-methionyl-leucyl-phenylalanine. Its chemotactic activity is sensitive to the enzymatic effect of trypsin. Although producing a single elution peak on gelfiltration chromatography, electrofocusing in polyacrylamide gels yielded five peaks of radioactivity. Chemotactic activity was localized to a fraction with a pI = 5.0. The smaller molecular weight substance has been less well characterized. Thus, the human AM can produce at least two factors which attract PMN and this capability may augment the local inflammatory response in the lung. Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a mechanism by which these cells, after phagocytic challenge, may control or amplify the inflammatory response in lung parenchyma. Normal human alveolar macrophages (AM) were studied from eight subjects. With in vitro culture, AM produced and released two substances into culture media which have potent chemoattractant activity for blood polymorphonuclear granulocytes (PMN) and negligible activity for mononuclear cells. Release of these factors is maximally stimulated by aggregated human immunoglobulin (Ig)G or zymosan particles; however, simple adhesion of the macrophages to plastic surfaces is also sufficient to stimulate release of these chemotactic substances. The larger substance (10,000 daltons) is immunologically distinct from C5a and interacts with a different PMN membrane receptor than that known to exist for formyl-methionyl-leucyl-phenylalanine. Its chemotactic activity is sensitive to the enzymatic effect of trypsin. Although producing a single elution peak on gelfiltration chromatography, electrofocusing in polyacrylamide gels yielded five peaks of radioactivity. Chemotactic activity was localized to a fraction with a pI = 5.0. The smaller molecular weight substance has been less well characterized. Thus, the human AM can produce at least two factors which attract PMN and this capability may augment the local inflammatory response in the lung. |
Author | Naegel, G P Reynolds, H Y Merrill, W W Matthay, R A |
Author_xml | – sequence: 1 givenname: W W surname: Merrill fullname: Merrill, W W – sequence: 2 givenname: G P surname: Naegel fullname: Naegel, G P – sequence: 3 givenname: R A surname: Matthay fullname: Matthay, R A – sequence: 4 givenname: H Y surname: Reynolds fullname: Reynolds, H Y |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7356678$$D View this record in MEDLINE/PubMed |
BookMark | eNplkUtPHDEQhH1YRHjkkB8QySckDhNsjx-zkXJAq0A2QuICZ6vXY7NOPPbEnl2J_HoMbFCAU6tV9VVL1YdoFlO0CH2i5Aulip39XCwpmUvZzdABIYw2c9V2H9BhKb8IoZwLvo_2VSukVN0BCudha1OAjAcwOY1ruLNNb7Pf2h6btR3SBGbyBrs6Uv6Kf_to615wcthHvPVTTnjMqd9UW4oYYo9HyJOHUHnIFatpf-FRPEZ7DkKxH3fzCN1efL9Z_Giuri-Xi_OrxrCOd42DjighXMsUrFbKSeKk6Kjl1CkrGRNAKTOtoXNlBGOSgwEQSijWOc44bY_Qt-fccbMabG9snDIEPWY_QL7XCbx-rUS_1ndpq1tFW9lW_mTH5_RnY8ukB1-MDQGiTZuiFa_9EsGq8fP_h14u7Oqt-tmzXqstJVunjZ-eqqhnfdCU6Mef6ZefVeL0DfEv8733Ae2ImtY |
CitedBy_id | crossref_primary_10_1111_j_1365_2222_1991_tb00798_x crossref_primary_10_1016_0041_008X_82_90057_6 crossref_primary_10_3109_tcic_7_1_34_38 crossref_primary_10_1111_j_1749_6632_1991_tb17015_x crossref_primary_10_1016_S0025_7125_16_31517_6 crossref_primary_10_1164_ajrccm_136_4_811 crossref_primary_10_1007_BF02713886 crossref_primary_10_1097_00000441_198605000_00013 crossref_primary_10_1007_BF01964115 crossref_primary_10_3109_01902148609061491 crossref_primary_10_1016_S0272_5231_21_00164_7 crossref_primary_10_1016_S1047_9651_18_30393_0 crossref_primary_10_1016_0090_1229_87_90069_9 crossref_primary_10_3109_10408369009105897 crossref_primary_10_1016_0090_1229_83_90065_X crossref_primary_10_1016_0008_8749_80_90219_1 crossref_primary_10_3389_fimmu_2015_00278 crossref_primary_10_1111_j_1574_6968_1990_tb13834_x crossref_primary_10_1007_BF01982632 crossref_primary_10_1016_0002_9343_81_90577_5 crossref_primary_10_1165_ajrcmb_27_1_f243 crossref_primary_10_1016_0165_2427_85_90039_X crossref_primary_10_1111_j_1530_0277_1995_tb01465_x crossref_primary_10_1016_0006_291X_87_90432_3 crossref_primary_10_1007_BF02713638 crossref_primary_10_1002__SICI_1097_4652_199612_169_3_429__AID_JCP3_3_0_CO_2_Q crossref_primary_10_1164_ajrccm_138_6_1464 crossref_primary_10_1016_0090_6980_91_90101_K crossref_primary_10_1016_S0272_5231_21_01032_7 crossref_primary_10_1021_acsbiomaterials_8b00579 crossref_primary_10_3109_01902148409087907 crossref_primary_10_1080_15287398509530791 crossref_primary_10_1016_S0960_5428_06_80037_9 crossref_primary_10_1016_S0300_2896_15_31560_X crossref_primary_10_1056_NEJM198401193100304 crossref_primary_10_1016_0090_1229_87_90158_9 crossref_primary_10_1164_ajrccm_142_1_57 crossref_primary_10_1002_ddr_430100406 crossref_primary_10_1164_ajrccm_141_3_683 crossref_primary_10_1378_chest_95_5_1021 crossref_primary_10_4049_jimmunol_1801485 crossref_primary_10_1016_0738_081X_86_90031_3 crossref_primary_10_1002_jat_2550080602 crossref_primary_10_1371_journal_pone_0247125 crossref_primary_10_1378_chest_80_1_Supplement_3S crossref_primary_10_1111_j_1476_5381_1989_tb12638_x crossref_primary_10_1016_S0022_3476_86_80761_2 crossref_primary_10_1016_0011_5029_85_90010_0 crossref_primary_10_1016_S0300_2896_15_31776_2 crossref_primary_10_1378_chest_91_1_44 crossref_primary_10_1097_00063198_200205000_00002 crossref_primary_10_1164_ajrccm_148_6_Pt_1_1671 crossref_primary_10_1378_chest_91_1_118 crossref_primary_10_1016_S0003_4975_10_61044_2 crossref_primary_10_1016_0002_9343_84_90242_0 crossref_primary_10_1164_ajrccm_139_1_39 crossref_primary_10_3109_01902148409069668 crossref_primary_10_1016_S0889_8561_22_00270_3 crossref_primary_10_1164_ajrccm_136_2_288 crossref_primary_10_1016_0014_2999_86_90337_7 crossref_primary_10_1016_0002_9343_90_90256_D crossref_primary_10_1016_S0006_291X_88_80711_3 crossref_primary_10_1111_j_1749_6632_1985_tb20814_x crossref_primary_10_1164_rccm_200406_788PP crossref_primary_10_1007_BF02719671 crossref_primary_10_1007_BF02028296 crossref_primary_10_1016_S0272_5231_21_00185_4 crossref_primary_10_3109_01902148609058286 crossref_primary_10_1016_0041_008X_86_90262_0 crossref_primary_10_1016_0167_5699_81_90093_1 crossref_primary_10_1136_mp_48_4_M210 crossref_primary_10_1164_ajrccm_139_1_22 crossref_primary_10_3109_01902148809115121 crossref_primary_10_1016_0300_483X_81_90102_5 crossref_primary_10_1016_S0272_5231_21_01041_8 crossref_primary_10_1111_j_1749_6632_1996_tb32565_x crossref_primary_10_1152_ajplung_1998_275_4_L687 crossref_primary_10_1007_BF01966691 crossref_primary_10_1164_ajrccm_138_4_921 crossref_primary_10_1097_00000441_198902000_00005 crossref_primary_10_1152_ajplung_1998_275_1_L87 crossref_primary_10_1152_ajplung_00405_2003 crossref_primary_10_1378_chest_94_3_521 crossref_primary_10_1016_S0021_9258_18_92996_0 crossref_primary_10_1056_NEJM198310133091502 crossref_primary_10_1378_chest_83_5_Supplement_1S_a crossref_primary_10_1097_00000441_198812000_00003 crossref_primary_10_1002_bio_1170080305 crossref_primary_10_1164_ajrccm_145_2_Pt_2_S27 crossref_primary_10_1016_S0002_9440_10_65702_1 crossref_primary_10_1164_rccm_201307_1317OE crossref_primary_10_3109_01902148009069652 crossref_primary_10_1016_0165_2427_91_90022_5 crossref_primary_10_1016_S0889_8561_22_00116_3 crossref_primary_10_1136_thx_37_11_803 crossref_primary_10_1111_j_1365_2222_1994_tb00247_x crossref_primary_10_1164_ajrccm_137_1_38 crossref_primary_10_1016_0091_6749_89_90005_5 crossref_primary_10_1097_00003246_199904000_00008 crossref_primary_10_3109_01902149009087877 crossref_primary_10_1007_BF00916297 crossref_primary_10_1016_0011_5029_87_90010_1 crossref_primary_10_1016_0952_3278_89_90188_9 crossref_primary_10_1016_0041_008X_86_90417_5 crossref_primary_10_1016_0300_483X_85_90114_3 crossref_primary_10_1016_S0300_2896_15_31925_6 crossref_primary_10_1164_ajrccm_139_2_373 crossref_primary_10_1007_BF02116375 crossref_primary_10_3109_07357909309046949 crossref_primary_10_1016_S0033_8389_22_01118_6 crossref_primary_10_3109_01902149109062879 crossref_primary_10_4049_jimmunol_175_9_5567 crossref_primary_10_1016_S0012_3692_16_57764_2 crossref_primary_10_1164_ajrccm_140_6_1595 crossref_primary_10_4049_jimmunol_162_10_6200 crossref_primary_10_1016_S0272_5231_21_00170_2 crossref_primary_10_3109_01902148809087821 crossref_primary_10_1164_ajrccm_145_1_85 crossref_primary_10_1016_0014_4827_92_90358_F crossref_primary_10_1136_thx_40_5_321 crossref_primary_10_1016_S0272_5231_21_00132_5 crossref_primary_10_3109_01902148809087827 crossref_primary_10_1046_j_1440_1746_1999_01880_x crossref_primary_10_1124_jpet_109_163253 crossref_primary_10_3109_10408448909037474 crossref_primary_10_1111_j_1348_0421_1990_tb01003_x crossref_primary_10_3109_01902148309061522 crossref_primary_10_1111_j_1365_2222_1990_tb03138_x |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1172/JCI109668 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 276 |
ExternalDocumentID | PMC371363 7356678 10_1172_JCI109668 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article Comparative Study |
GroupedDBID | --- -~X .55 .GJ 29K 2WC 3O- 53G 5GY 5RE 8F7 AAWTL AAYXX ABOCM ACGFO ACIHN ACNCT ACPRK ADBBV AEAQA AENEX AFFNX AHMBA AI. ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EJD EMB F5P FRP GROUPED_DOAJ GX1 HYE H~9 IAO IEA IHR INH IOF IPO J5H KQ8 L7B M1P MVM OK1 OVT P2P P6G RPM TEORI TR2 TVE VH1 VVN W2D WH7 WOQ WOW X7M YOC ZGI ZXP ZY1 .XZ 08G 08P 354 36B 3V. 5RS 7RV 7X7 88A 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AAKAS AAYOK ABPMR ABUWG ADZCM AFCHL AFKRA ASPBG AVWKF AZFZN BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CGR CUY CVF EBD ECM EIF EMOBN EX3 FEDTE FYUFA HCIFZ HMCUK HVGLF IHW INR IOV ISR ITC LK8 M0L M5~ M7P N4W NAPCQ NPM OBH OCB ODZKP OFXIZ OGEVE OHH OHT OVD OVIDX PKN PQQKQ PROAC PSQYO Q2X S0X SJFOW SV3 UHU UKHRP XSB YFH YHG YKV ~H1 7X8 5PM |
ID | FETCH-LOGICAL-c2848-fa80755f327abb7f60f6581e41f7e6225a112c3c197c52264acaa575728f42413 |
ISSN | 0021-9738 |
IngestDate | Thu Aug 21 18:13:04 EDT 2025 Fri Jul 11 07:29:54 EDT 2025 Wed Feb 19 01:03:51 EST 2025 Tue Jul 01 01:42:52 EDT 2025 Thu Apr 24 22:54:07 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2848-fa80755f327abb7f60f6581e41f7e6225a112c3c197c52264acaa575728f42413 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | http://www.jci.org/articles/view/109668/files/pdf |
PMID | 7356678 |
PQID | 74966052 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_371363 proquest_miscellaneous_74966052 pubmed_primary_7356678 crossref_citationtrail_10_1172_JCI109668 crossref_primary_10_1172_JCI109668 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19800201 |
PublicationDateYYYYMMDD | 1980-02-01 |
PublicationDate_xml | – month: 2 year: 1980 text: 19800201 day: 1 |
PublicationDecade | 1980 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 1980 |
References | 641351 - J Immunol. 1978 Apr;120(4):1326-32 807240 - Biochemistry. 1975 Jul;14(13):2853-60 14113111 - J Exp Med. 1964 Jan 1;119:167-76 4568301 - J Exp Med. 1973 Feb 1;137(2):387-410 619716 - Am Rev Respir Dis. 1978 Jan;117(1):15-23 807599 - J Clin Invest. 1975 Aug;56(2):376-85 14450081 - Nature. 1962 May 5;194:495-6 334799 - J Clin Invest. 1977 Dec;60(6):1280-8 13718021 - J Immunol. 1960 Aug;85:163-71 320925 - Am Rev Respir Dis. 1977 Mar;115(3):479-514 1088938 - Clin Immunol Immunopathol. 1975 Jan;3(3):334-46 4853956 - J Clin Invest. 1974 Sep;54(3):519-28 140184 - J Clin Invest. 1977 May;59(5):951-8 4412011 - J Lab Clin Med. 1974 Oct;84(4):559-73 4179068 - Scand J Clin Lab Invest Suppl. 1968;97:77-89 830662 - J Clin Invest. 1977 Jan;59(1):179-83 401834 - J Clin Invest. 1977 Feb;59(2):273-81 4132993 - J Exp Med. 1974 May 1;139(5):1175-88 13554587 - Proc Soc Exp Biol Med. 1958 May;98(1):188-92 582028 - Chest. 1979 Feb;75(2 Suppl):239-42 4996883 - J Clin Invest. 1971 Jul;50(7):1390-8 178186 - Am J Pathol. 1976 May;83(2):396-418 789778 - J Immunol Methods. 1976;13(2):191-7 1262785 - J Exp Med. 1976 May 1;143(5):1154-69 4712920 - J Immunol. 1973 Jun;110(6):1455-63 106197 - Lipids. 1979 Feb;14(2):181-93 14112262 - J Exp Med. 1963 Dec 1;118:1009-20 |
References_xml | – reference: 4132993 - J Exp Med. 1974 May 1;139(5):1175-88 – reference: 1088938 - Clin Immunol Immunopathol. 1975 Jan;3(3):334-46 – reference: 807599 - J Clin Invest. 1975 Aug;56(2):376-85 – reference: 140184 - J Clin Invest. 1977 May;59(5):951-8 – reference: 830662 - J Clin Invest. 1977 Jan;59(1):179-83 – reference: 4412011 - J Lab Clin Med. 1974 Oct;84(4):559-73 – reference: 13718021 - J Immunol. 1960 Aug;85:163-71 – reference: 334799 - J Clin Invest. 1977 Dec;60(6):1280-8 – reference: 178186 - Am J Pathol. 1976 May;83(2):396-418 – reference: 1262785 - J Exp Med. 1976 May 1;143(5):1154-69 – reference: 320925 - Am Rev Respir Dis. 1977 Mar;115(3):479-514 – reference: 4996883 - J Clin Invest. 1971 Jul;50(7):1390-8 – reference: 789778 - J Immunol Methods. 1976;13(2):191-7 – reference: 4853956 - J Clin Invest. 1974 Sep;54(3):519-28 – reference: 106197 - Lipids. 1979 Feb;14(2):181-93 – reference: 14450081 - Nature. 1962 May 5;194:495-6 – reference: 641351 - J Immunol. 1978 Apr;120(4):1326-32 – reference: 582028 - Chest. 1979 Feb;75(2 Suppl):239-42 – reference: 807240 - Biochemistry. 1975 Jul;14(13):2853-60 – reference: 4568301 - J Exp Med. 1973 Feb 1;137(2):387-410 – reference: 14113111 - J Exp Med. 1964 Jan 1;119:167-76 – reference: 4179068 - Scand J Clin Lab Invest Suppl. 1968;97:77-89 – reference: 619716 - Am Rev Respir Dis. 1978 Jan;117(1):15-23 – reference: 13554587 - Proc Soc Exp Biol Med. 1958 May;98(1):188-92 – reference: 14112262 - J Exp Med. 1963 Dec 1;118:1009-20 – reference: 4712920 - J Immunol. 1973 Jun;110(6):1455-63 – reference: 401834 - J Clin Invest. 1977 Feb;59(2):273-81 |
SSID | ssj0014454 |
Score | 1.4335387 |
Snippet | Alveolar macrophages are the initial phagocytic cells that encounter foreign material and particulates deposited in the terminal airways. We have examined a... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 268 |
SubjectTerms | Cells, Cultured Chemotactic Factors - biosynthesis Chemotactic Factors - pharmacology Female Granulocytes - drug effects Humans Immunoglobulin G - administration & dosage In Vitro Techniques Kinetics Leukocytes - drug effects Macrophages - metabolism Male Molecular Weight Pulmonary Alveoli - metabolism Smoking - physiopathology Zymosan - pharmacology |
Title | Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7356678 https://www.proquest.com/docview/74966052 https://pubmed.ncbi.nlm.nih.gov/PMC371363 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbB2MvY91Wln1VjD0MgjZ_KFbct1Ja0q7JYCQsb0a2ZJous0eXBNa_vneSLCdNYR8vJtiOFPz75XTn0_2OkPehkjmQN2ChTgXj_SJgsMoVLI-DSMECmxemx9JwlAwm_Gzam7byBKa6ZJF_LK7vrCv5H1ThHOCKVbL_gKwfFE7AZ8AXjoAwHP8K48P5SmNo2v0hsRPXBdgGpmDiFXiRAAagYEqgXFMdDP6_g1NphJmNUkR3NVtc1bhHSy1dy3CUDcCZUDbEazlft_Bdtuxa82V9feWsle1o8_tDVH-06Y1vXf9OZyQxXW_ey7dFZqb9uLTAt69Zv-rfVT1XhnIDt2IoW7oH-Ad-10dTORCyVFg1l8b62k4RjmXRuim17Xa2TbxAydizo9MQoi97z6aM9uhLdjI5P8_Gx9PxffIggvjBxNqnn316ifOek-e2P8hJTsHQn_zAm47KVvRxexPtmlcyfkIeOwjooeXGLrmnq6fk4dBtmHhG5g1F6DZF6BpFqKXIAW0IQuuSzipqCEJbglAgCHUEobcJ8pxMTo7HRwPmGmywArySPislSlH3yjgSMs9FmQQlOKSh5mEpdAKWXoI3XsTwdxUF-ulcFlKCfy-ifskxIbtHdqq60i8ITUWg0LZjnpXDMgJ-d5lqcEZFqnQZqA750DzNrHDq89gEZZ6ZKFREmX_wHfLO3_rTSq7cddN-A0kGBhGzXLLS9fJXJjgKzvaiDtmzAPlBRAyxi4CvJhvI-euotL55pZpdGMX1WIRxEr_845yvyCNDfLPd6TXZWVwt9RtwWhf5W0PAG9nynT8 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alveolar+macrophage-derived+chemotactic+factor%3A+kinetics+of+in+vitro+production+and+partial+characterization&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Merrill%2C+W+W&rft.au=Naegel%2C+G+P&rft.au=Matthay%2C+R+A&rft.au=Reynolds%2C+H+Y&rft.date=1980-02-01&rft.issn=0021-9738&rft.volume=65&rft.issue=2&rft.spage=268&rft_id=info:doi/10.1172%2FJCI109668&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |